Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, ...

Phillip Chan; Chief Executive Officer, Director; Cytosorbents Corp. Peter Mariani; Chief Financial Officer; Cyt ...

Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsAdanna Alexander – IRPhillip Chan - ...

The decision to move forward with a heart transplant is made when all other treatment options been unsuccessful.

What do the upcoming trends in medical devices look like? In the fast-changing healthcare sector, keeping up-to-date with the newest developments in medical technology is crucial for experts and ...